Monthly intravenous maintenance treatment with ustekinumab regains clinical response in patients with Crohn’s disease who no longer respond to the drug when administered subcutaneously

Monthly intravenous maintenance treatment with ustekinumab regains clinical response in patients with Crohn’s disease who no longer respond to the drug when administered subcutaneously

Background: Several studies have assessed the efficacy of re-induction and subcutaneous intensification of ustekinumab (UST) to regain clinical remission of inflammatory bowel disease (IBD). However, very few have evaluated the effectiveness of intravenous UST for this purpose. Objectives: The aims...

Full description

Saved in:
Bibliographic Details
Main Authors: Berta López-Sáez, Ariadna Altadill, Eduard Brunet-Mas, Belen Garcia-Sagué, Luigi Melcarne, Laura Patricia Llovet, Luis Enrique Frisancho, Anna Puy, Sergio Lario, Maria Jose Ramirez-Lazaro, Jorge Del Estal, Albert Villoria, Xavier Calvet Calvo
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848251358147
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/17562848251358147

Similar Items